U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Food
  3. News & Events from HFP
  4. Workshops, Meetings & Webinars on Food and Dietary Supplements
  5. Public Meeting on the Development of an Enhanced Systematic Process for FDA’s Post-Market Assessment of Chemicals in Food - 09/25/2024
  1. Workshops, Meetings & Webinars on Food and Dietary Supplements

Meeting | Mixed

Event Title
Public Meeting on the Development of an Enhanced Systematic Process for FDA’s Post-Market Assessment of Chemicals in Food
September 25, 2024

Date:
September 25, 2024

Background

The FDA is developing a systematic process for conducting post-market assessments of chemicals in food. This includes ingredients considered generally recognized as safe (GRAS), food additives, color additives, food contact substances, and contaminants. This is intended to guide our post-market assessment work going forward and includes a transparent process for identifying and prioritizing food chemicals currently in the market for safety reviews. This project is part of a larger enhanced approach for food chemical safety.

The FDA will host a public meeting to share the agency’s enhanced systematic process for post-market assessment of chemicals in food and hear stakeholder perspectives on this proposal. This information will help inform our thinking and further the development of the process.

Meeting Information

The FDA hosted this public meeting on Wednesday, September 25, 2024, from 12:30 – 5:30 PM ET. The meeting was held in-person at the FDA White Oak Campus, 10903 New Hampshire Avenue, Silver Spring, MD 20993 with an option for virtual participation as well. In-person attendance encouraged but limited to the meeting space capacity of 270.

Meeting Recording

Public Meeting Transcript

Public Comments

You may submit comments to the docket FDA-2024-N-3609. Please note that late, untimely filed comments will not be considered. Comments must be submitted on or before January 21, 2025. The https://www.regulations.gov electronic filing system will accept comments until 11:59 p.m. Eastern Time at the end of January 21, 2025. Written/paper submissions should be sent to Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. Comments received by mail/hand delivery/courier (for written/paper submissions) will be considered timely if they are postmarked or the delivery service acceptance receipt is on or before that date.

We invite interested persons, including those participating in the public meeting, to provide information on topics related to the process outlined in the discussion paper. In particular, we welcome feedback on the following questions.

For Further Information

For general questions about the public meeting, contact CFSAN Communications and Public Engagement Staff at CFSAN-Comms@fda.hhs.gov.

Back to Top